Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › H2020

IMI-PainCare · Improving the care of patients suffering from acute or chronic pain

H2020Status: CLOSED1 April 201831 March 2023EU funding €11,225,271Call H2020-JTI-IMI2-2016-10-two-stage

There is a very high need for improving the management of pain. Acute and persistent pain of different origins represent a common medical, social, and economic burden, and its pharmacotherapy is often inadequate. To advance management of pain patients and support decision making in clinical practice, more predictive assessments of treatment success are needed. The development of analgesics is onerous because promising preclinical data often do not translate into the clinic. Improved pharmacodynamic biomarkers could define whether nociceptive signalling is adequately modulated by a new drug, so increasing the chance of successful translation and greatly reducing the risk in initiating clinical development. Further, the pathophysiology of chronic pelvic pain indications is poorly understood and no adequate preclinical models are available, precluding focused preclinical research and leaving affected patients with little hope of relief. IMI-PainCare aims at making advances in these three pain areas in a complementary manner. Three subprojects will address specific scientific challenges. Subproject PROMPT will identify Patient Reported Outcome Measures as tools to standardise assessments of treatment success of acute and chronic pain in Real World conditions and controlled trials, and so improve its management; subproject BioPain will validate the translatability of pharmacodynamic biomarkers and PK-PD modelling in pain pathways of healthy subjects and preclinical species, thereby offering tools to improve drug development; subprojectTRiPP will identify biomarkers and novel therapeutic pathways of clinical phenotypes of patients with chronic pelvic pain, which after back-translation, can improve how preclinical models reflecting human diseases.The goal of IMI-PainCare is to improve the care of patients with acute or chronic pain by providing a toolbox to streamline the development process for novel analgesic drugs and to improve treatment quality in clinical practice.

Consortium · 41 organisations

coordinator

RUPRECHT-KARLS-UNIVERSITAET HEIDELBERG

DE · €1,019,588

participant

ENDODIAG

FR

participant

NOVARTIS PHARMA AG

CH

participant

KING'S COLLEGE LONDON

UK · €293,808

participant

FUNDACION PARA LA INVESTIGACION DEL HOSPITAL CLINICO DE LA COMUNITAT VALENCIANA, FUNDACION INCLIVA

ES · €257,066

participant

AARHUS UNIVERSITET

DK · €555,713

participant

UNIVERSITAET MUENSTER

DE · €1,064,750

participant

REGION HOVEDSTADEN

DK · €7,500

participant

MICHIGAN STATE UNIVERSITY

US · €29,549

participant

INSTITUTO DE BIOLOGIA MOLECULAR E CELULAR-IBMC

PT · €351,901

participant

HUS-YHTYMA

FI · €187,250

participant

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE

FR · €881,329

participant

CONSULTECH TECHNOLOGIEBERATUNG GMBH

DE · €486,266

participant

TEVA PHARMACEUTICAL INDUSTRIES LIMITED

IL

participant

PROMPTLY - SOFTWARE SOLUTIONS FOR HEALTH MEASURES SA

PT · €30,000

participant

ACTUAL ANALYTICS LTD

UK · €114,413

participant

ASSISTANCE PUBLIQUE HOPITAUX DE PARIS

FR · €295,038

participant

EUROPEAN SOCIETY OF ANAESTHESIOLOGY AND INTENSIVE CARE AISBL

BE · €25,000

participant

UNIVERSITE CATHOLIQUE DE LOUVAIN

BE · €552,488

participant

CLINIQUES UNIVERSITAIRES SAINT-LUC ASBL

BE · €134,044

participant

CHRISTIAN-ALBRECHTS-UNIVERSITAET ZU KIEL

DE · €255,000

participant

EUROPEAN SOCIETY OF REGIONAL ANAESTHESIA AND PAIN THERAPY

CH · €25,000

participant

MRC SYSTEMS GMBH MEDIZINTECHNISCHE SYSTEME

DE · €144,000

participant

NEUROSCIENCE TECHNOLOGIES SLP

ES

participant

UNIVERSIDAD DE NAVARRA

ES · €123,500

participant

CHILDREN'S HOSPITAL CORPORATION

US · €165,668

participant

STICHTING INTERNATIONAL PAINFUL BLADDER FOUNDATION

NL · €7,510

participant

ENDOMETRIOSIS.ORG LTD

UK · €7,510

participant

GRUNENTHAL GMBH

DE

participant

BAYER AKTIENGESELLSCHAFT

DE

participant

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD

UK · €1,592,860

participant

EUROPEAN PAIN FEDERATION EFIC

BE · €31,250

participant

QUEEN MARY UNIVERSITY OF LONDON

UK · €21,484

participant

ESTEVE PHARMACEUTICALS, SA

ES

participant

ELI LILLY AND COMPANY LTD

UK

participant

UNIVERSITY COLLEGE CORK - NATIONAL UNIVERSITY OF IRELAND, CORK

IE · €68,687

participant

AALBORG UNIVERSITET

DK · €18,770

participant

PELVIC PAIN SUPPORT NETWORK

UK · €7,510

participant

THE UNIVERSITY OF EDINBURGH

UK · €288,953

participant

UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA

IT · €573,288

participant

UNIVERSITATSKLINIKUM JENA

DE · €1,608,584

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.